Athenahealth
PrivateLast Round
Debt
May 11, 2026
Est. Valuation
$17B
Total Funding Raised
$55.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Athenahealth operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series E round in April 2004.
Athenahealth is a healthcare technology company that provides medical practice automation and claims management software for medical groups and health systems.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Revenue Cycle, Vertical SaaS, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Revenue Share, Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Athenahealth Comparables
Compare Athenahealth with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| eClinicalWorks | 88% | |
| NextGen Healthcare, Inc. | 82% | |
| ModMed | 82% |
For institutional investors. Book with your work email.
Athenahealth Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 11, 2026 | ||||
| Buyout/LBO | Feb 15, 2022 | ||||
| Buyout/LBO | Feb 11, 2019 | ||||
| IPO | Sep 19, 2007 | ||||
| Series E | Apr 16, 2004 | ||||
Debt | Nov 1, 2003 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Athenahealth Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| Veritas Capital | Buyout/LBO |
| Hellman & Friedman | Buyout/LBO |
| GIC Private Limited | Buyout/LBO |
| Oak Investment Partners | Series D, Series E |
| Draper Fisher Jurvetson Management | Series D |
| Bain Capital, LP | Buyout/LBO |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2026
Solutions used by over 170,000 healthcare providers daily.
- Oct 6, 2026
Recognized as 'Best In KLAS' for its product suite.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 3, 2026
Athenahealth, Inc. and Availity have previously collaborated on electronic prior authorization.
- partners_withNov 3, 2026
Athenahealth, Inc. partners with Claude as athenaPatient MCP’s first partner to connect patient records to AI.
- launchesNov 3, 2026
Athenahealth, Inc. launches the athenaPatient MCP server, enabling patients to securely share authorized medical records with Anthropic’s Claude for personalized health insights on Nov 3rd '26.
- partners_withNov 3, 2026
On Nov 3rd '26, Athenahealth, Inc. and Humana, Inc. are identified as having previously collaborated on prior authorization as they expand electronic capabilities across more than 180,000 clinicians.
- integrates_withNov 2, 2026
Athenahealth, Inc. launches athenaPatient MCP to integrate with Anthropic Limited's Claude, connecting official patient records for conversational interpretation; the integration is live for Claude Pro and Claude Max subscribers across United States on Nov 2nd '26.
For institutional investors. Book with your work email.
Athenahealth Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Appears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Athenahealth's valuation, stock price, and market status.
Is Athenahealth a public or private company?
Athenahealth is a private company.
What is the current stock price of Athenahealth?
Athenahealth is a private company, so its shares have no public market price. Caplight tracks Athenahealth's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Athenahealth worth (valuation)?
Athenahealth's valuation is estimated at $17.0B based on funding round data.
Can I buy Athenahealth stock?
Athenahealth shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Athenahealth's last funding round?
Athenahealth's most recent funding round was Debt on May 11, 2026.
Who are the main investors in Athenahealth?
Key investors in Athenahealth include Veritas Capital, Hellman & Friedman, Oak Investment Partners, Bain Capital, LP, Goldman Sachs & Co. LLC.
Will Athenahealth IPO soon?
No public IPO plans have been announced for Athenahealth.
How can I track Athenahealth secondary market activity?
Caplight tracks bids, offers, and trades in Athenahealth's shares on secondary markets.